Recent Finacing
Recent Raise
Medial EarlySign provides an AI platform analyzing routine blood tests, lab and EHR data to stratify populations and support clinical decision-making with AlgoMarker models for cancer, diabetes, and complications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Medial EarlySign.
